Providers

MATIAS CLINICAL LABORATORY INC

NPI 1962546176, organization, Baldwin Park, CA, Clinical Medical Laboratory

1
Evidence tier
documented action, then payment
  • Listed on the Medicare revocation list since August 31, 2018.
  • Medicaid still paid claims in 44 later months, $3,846,471 in total.
  • Adjudicated (sentenced) per a Department of Justice release dated January 30, 2024.
score 97 of 100, rank 43, $3.8M at stake

Public list actions

Medicare revocation effective August 31, 2018, barred from re-enrolling until November 22, 2034
424.535(a)(4) false or misleading information and 424.535(a)(3) felonies and 424.535(a)(2) provider or supplier conduct (exclusion), Part B Supplier - Independent Clinical Laboratory, CA

Paid after the action

Months in which Medicaid paid claims for this provider after a public action that should have triggered a screening check. This is a record of payments, not a determination that they were improper.

listidentity checkaction datewindow closedmonths paid afterfirstlastpaid after12 months before
CA Medicaid exclusion list
ca medi-cal suspended & ineligible provider list (july 2026)
Exact NPI, name conflict (set aside)Aug 31, 2018still open44Sep 2018Apr 2022$3.8M$312K
Medicare revocation list
424.535(a)(4) false or misleading information and 424.535(a)(3) felonies and 424.535(a)(2) provider or supplier conduct (exclusion)
Exact NPI, name verifiedAug 31, 2018Nov 22, 203444Sep 2018Apr 2022$3.8M$312K

National provider registry

From the CMS NPPES Registry, refreshed daily.

NameMATIAS CLINICAL LABORATORY INC (also HEALTH CARE PROVIDERS LABORATORY INC)
TypeOrganization
StatusActive
NPI issuedFebruary 19, 2007, last updated August 7, 2020
Practice location14411 PALMROSE STREET, Baldwin Park, CA 91706, 626-813-3800
Authorized officialEMILIO VILLARBA (President)
Specialties
Clinical Medical Laboratory (291U00000X, primary)

Procedures billed

The specific codes behind the dollars. Medicaid figures come from T-MSIS (2018 to 2024) and are compared with every other provider billing the same code; Medicare figures come from the 2024 physician and supplier file and compare this provider's submitted charge with what Medicare allowed, against the usual ratio for that code.

Medicaid, largest codes
codewhat it ispaidshareper patient-monthtypicalrank among providers
U0003Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r$730K18%$120$75 (top 5% from $185)88th percentile
87798Detection test by nucleic acid for organism, amplified probe technique$673K17%$64$33 (top 5% from $227)75th percentile
87502Detection test by nucleic acid for multiple types influenza virus$349K9%$55$71 (top 5% from $112)31st percentile
87631Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets$279K7%$52$74 (top 5% from $182)33rd percentile
87634Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique$258K7%$41$48 (top 5% from $77)39th percentile
G0483Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms$207K5%$118$146 (top 5% from $318)38th percentile
G2023Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source$174K4%$33$20 (top 5% from $39)92nd percentile
87486Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique$156K4%$24$23 (top 5% from $56)52nd percentile

In this area

399 providers in Los Angeles County, CA carry an indicator in the public record, with $125.8M at stake between them. The most common is part of a provider network, on 347 of them, followed by paid after a public list action on 36. 52 are tier 1: documented action, then payment.

tierproviderat stakewhy
1BURBANK PREFERRED PROVIDER MEDICAL GROUP, INC
Burbank, CA, ranked 17
$67K
  • Listed on the Medicare revocation list since October 21, 2020.
  • Medicaid still paid claims in 24 later months, $67,101 in total.
  • and 1 more
1GOLDEN STAR LABS LLC
Los Angeles, CA, ranked 32
$41.0M
  • Adjudicated (pleaded guilty) per a Department of Justice release dated June 24, 2026.
  • Medicaid paid $41,015,276 in the last 12 observed months.
1HEALTHSMART PACIFIC INC
Long Beach, CA, ranked 52
$1.6M
  • Listed on the OIG exclusion list since April 20, 2021.
  • Medicaid still paid claims in 34 later months, $1,639,221 in total.
1LINDA WARREN-WATSON
Lancaster, CA, ranked 71
$828K
  • Listed on the CA Medicaid exclusion list since October 31, 2020.
  • Medicaid still paid claims in 16 later months, $828,250 in total.
1SOHRAB MOSHIRI
Woodland Hills, CA, ranked 82
$483K
  • Listed on the WA Medicaid exclusion list since January 9, 2009.
  • Medicaid still paid claims in 83 later months, $482,999 in total.
1QUALITY FAMILY HOSPICE CARE INC
Tarzana, CA, ranked 92
$375K
  • Listed on the CA Medicaid exclusion list and the Medicare revocation list since July 18, 2024.
  • Medicaid still paid claims in 4 later months, $375,479 in total.
1MARATHON HOSPICE CARE INC.
North Hollywood, CA, ranked 95
$368K
  • Listed on the Medicare revocation list since July 6, 2024.
  • Medicaid still paid claims in 4 later months, $367,866 in total.
1SOFT TOUCH HOSPICE, INC
Glendale, CA, ranked 106
$247K
  • Listed on the Medicare revocation list and the CA Medicaid exclusion list since August 17, 2024.
  • Medicaid still paid claims in 2 later months, $246,792 in total.
All 399 in CA

Recent enforcement in CA

All releases

Department of Justice and HHS-OIG releases for this state, newest first. Each opens in a new tab.

DOJPleaded guiltyAug 27, 2026
Anaheim Woman Pleads Guilty to Submitting More Than $2.2 Million in Fraudulent Hospice Care Claims to Medicare
Galbraith submitted approximately $2,266,694 in claims to Medicare for hospice services for beneficiaries who did not have a terminal illness with a life expectancy of six months or less, and Medicare paid her company approximately $2,140,606.
DOJCivil settlementAug 26, 2026
DermTech Inc. to Pay Up to $5M to Resolve Allegations It Submitted False Claims to Medicare for Unreliable Skin Cancer Tests
DermTech Inc. submitted claims to Medicare for skin cancer tests conducted with an unvalidated positive control range and for tests lacking sufficient patient RNA, and did not retract results or adequately refund Medicare.
DOJCivil settlementAug 26, 2026
DermTech Inc. to Pay Up to $5M to Resolve Allegations It Submitted False Claims to Medicare for Unreliable Skin Cancer Tests
DermTech Inc. billed Medicare for skin cancer tests conducted using an unvalidated positive control range and for tests with insufficient patient RNA, and did not retract the results or adequately refund Medicare.
DOJCivil settlementAug 24, 2026
Medicare Advantage Provider Monogram Health Agrees to Pay $2.4 Million to Settle False Claims Act Lawsuit
Monogram knowingly submitted diagnosis codes in four HCCs that were not clinically accurate, not supported by medical record documentation, and/or did not require or affect patient care, inflating Medicare Advantage beneficiaries' risk scores and causing CMS to make higher capitated payments to Medicare Advantage Organizations.
DOJCivil settlementAug 24, 2026
Medicare Advantage Provider Monogram Health Agrees to Pay $2.4M to Settle False Claims Act Suit
Monogram Health knowingly submitted diagnosis codes within four HCCs that were not clinically accurate, not supported by medical record documentation, and/or did not require or affect patient care, inflating Medicare Advantage beneficiaries' risk scores and causing CMS to make higher capitated payments to MAOs.

Referral packet

11 public records citedAwaiting review

Referral packet: MATIAS CLINICAL LABORATORY INC

Public records show NPI 1962546176, MATIAS CLINICAL LABORATORY INC, an organization laboratory in Baldwin Park, CA with a Medicaid home state of Missouri, was placed on the Medicare revocation list on August 31, 2018 under 424.535(A)(4), 424.535(A)(3) and 424.535(A)(2), with a re-enrollment bar running to November 22, 2034, and appears on the California Medi-Cal Suspended and Ineligible Provider List with the same action date. Medicaid records show $3,846,471 paid across 44 service months from September 2018 through April 2022, after that action date, which warrants a records request to confirm enrollment status, screening history and the basis for the later payments.

Description

This referral candidate is a clinical laboratory organization in Baldwin Park, California that bills Medicaid with Missouri listed as its home state. Records show it was revoked from Medicare on August 31, 2018 on three grounds, including false or misleading information and felonies, with a bar on re-enrolling until November 22, 2034, and it also appears on the California Medi-Cal Suspended and Ineligible Provider List with the same date. Medicaid records show payments continued after that date, totaling $3,846,471 over 44 service months from September 2018 through April 2022, compared with $312,286 in the twelve months before. Its largest paid code is the high throughput COVID-19 test U0003 at $729,801 over 24 months, priced at $120 per patient-month against a typical $75, which is the 88th percentile among providers billing that code. A second nucleic acid detection code, 87798, accounts for $672,654 over 49 months at $64 per patient-month against a typical $33.

What the records show
  1. 01NPI 1962546176 is registered to MATIAS CLINICAL LABORATORY INC, an organization in Baldwin Park, CA, with taxonomy 291U00000X and a Medicaid home state of MO. records 1
  2. 02The provider was revoked on 2018-08-31 under 424.535(A)(4) False Or Misleading Information, 424.535(A)(3) Felonies and 424.535(A)(2) Provider Or Supplier Conduct (Exclusion), with a re-enrollment bar to 2034-11-22. records 9
  3. 03After the Medicare revocation action of 2018-08-31, Medicaid paid $3,846,471 across 44 service months from 2018-09 to 2022-04, compared with $312,286 in the 12 months before. records 10
  4. 04After the California state exclusion action of 2018-08-31, tied to the California Medi-Cal Suspended and Ineligible Provider List, Medicaid paid $3,846,471 across 44 service months from 2018-09 to 2022-04. records 11
  5. 05The record is classified as evidence tier 1, documented action then payment, with detector D3 and dollars at risk of $3,846,471, described as the figure of the detector that set the tier and not a sum. records 8
  6. 06Code U0003, the high throughput SARS-CoV-2 nucleic acid detection test, was paid $729,801 over 24 months, 18 percent of this provider's Medicaid dollars, at $120 per patient-month, ranking at the 88th percentile of all providers billing this code against a typical $75. records 2
  7. 07Code 87798, detection test by nucleic acid for organism, amplified probe technique, was paid $672,654 over 49 months, 17 percent of this provider's Medicaid dollars, at $64 per patient-month, ranking at the 75th percentile against a typical $33. records 3
  8. 08Code 87502, detection test by nucleic acid for multiple types influenza virus, was paid $348,859 over 49 months, 9 percent of this provider's Medicaid dollars, at $55 per patient-month, ranking at the 31st percentile against a typical $71. records 4
  9. 09Code 87631, respiratory virus panel with 3 to 5 targets, was paid $279,418 over 31 months, 7 percent of this provider's Medicaid dollars, at $52 per patient-month, ranking at the 33rd percentile against a typical $74. records 5
  10. 10Code 87634, respiratory syncytial virus nucleic acid detection, was paid $258,473 over 48 months, 7 percent of this provider's Medicaid dollars, at $41 per patient-month, ranking at the 39th percentile against a typical $48. records 6
  11. 11Code G0483, definitive drug testing, was paid $206,715 over 25 months, 5 percent of this provider's Medicaid dollars, at $118 per patient-month, ranking at the 38th percentile against a typical $146. records 7
Regulations this relates to
42 CFR 455.416(c) the State Medicaid agency must deny or terminate the enrollment of any provider that is terminated on or after January 1, 2011 under Medicare or under the Medicaid program or CHIP of any other State and is included in the termination database under 455.417.
42 CFR 455.436 states must confirm identity and determine exclusion status through routine checks of the Social Security Death Master File, NPPES, the LEIE and the EPLS (now SAM), upon enrollment and reenrollment and, for the LEIE and EPLS, no less frequently than monthly.
42 CFR 455.23 the State Medicaid agency must suspend all Medicaid payments to a provider after determining there is a credible allegation of fraud for which an investigation is pending, unless there is good cause not to suspend or to suspend only in part; 455.23(d) requires referral to the Medicaid Fraud Control Unit.
42 CFR 424.535(a) Medicare revocation grounds; the basis of the Medicare action cited in the evidence (for example (a)(2) exclusion, (a)(3) felony, (a)(4) false or misleading information, (a)(5) not operational at the practice location, (a)(8) abuse of billing privileges).
Recommended next step

Request the full Medicaid enrollment file for NPI 1962546176, including the application, all revalidation and screening records, and any documentation of appeal, reinstatement or reversal of the Medicare revocation dated 2018-08-31 and of the California Medi-Cal Suspended and Ineligible listing. Confirm whether the provider appears in the termination database and whether denial or termination of enrollment was required under 42 CFR 455.416(c), and pull the monthly exclusion and NPPES screening logs required by 42 CFR 455.436 for the period September 2018 through April 2022 to establish when the state first matched this provider. Obtain the claim level detail behind the $3,846,471 paid across the 44 service months, with attention to the U0003 and 87798 lines and to whether claims were billed directly or through another billing entity, ordering provider or managed care plan. If the review supports a credible allegation of fraud, evaluate a full or partial payment suspension under 42 CFR 455.23(a) and make the referral to the Medicaid Fraud Control Unit required by 42 CFR 455.23(d), and document the specific 42 CFR 424.535(a) grounds cited in the Medicare action.

Procedures behind the dollars
programcodewhat it ispaidsharecomparison
MedicaidU0003Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r$730K
18%
88th percentile of providers on this code ($120 per patient-month, typical $75)
Medicaid87798Detection test by nucleic acid for organism, amplified probe technique$673K
17%
75th percentile of providers on this code ($64 per patient-month, typical $33)
Medicaid87502Detection test by nucleic acid for multiple types influenza virus$349K
9%
31st percentile of providers on this code ($55 per patient-month, typical $71)
Medicaid87631Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets$279K
7%
33rd percentile of providers on this code ($52 per patient-month, typical $74)
Medicaid87634Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique$258K
7%
39th percentile of providers on this code ($41 per patient-month, typical $48)
MedicaidG0483Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms$207K
5%
38th percentile of providers on this code ($118 per patient-month, typical $146)
Rule out first
  • The Medicare revocation may have been appealed, stayed or reversed, or the provider may have been reinstated, and the extract may not reflect the current status.
  • Payments after the action date can reflect claims for dates of service before the action, timely filing lags, adjustments, voids or recoupments already applied, so the paid amount may not equal net dollars retained.
  • The dollars at risk figure of $3,846,471 is described as the figure of the detector that set the tier and not a sum, so it should not be treated as a computed overpayment.
  • T-MSIS and exclusion list data carry reporting lag, and the California list citation references a July 2026 file, so effective dates and match logic must be verified against source records before conclusions are drawn.
  • The provider is a laboratory organization whose claims may be submitted under supervisory or referring provider billing conventions or through a managed care plan, so the entity receiving payment and the entity performing the service should be confirmed.
  • Higher per patient-month amounts for U0003 and 87798 can reflect legitimate test mix, panel composition, specimen volume during the COVID-19 period or state fee schedule differences rather than any billing irregularity.
  • Several codes, including 87502, 87631, 87634 and G0483, price below the typical amount and at low percentiles, which is not consistent with a uniform upcoding pattern.
  • Name and address similarity is not identity; confirm that the Baldwin Park, California entity paid by Missouri Medicaid is the same entity named on the revocation and state exclusion lists.
Sources, 11 public records
  1. 1. providers/NPPES: NPI 1962546176 MATIAS CLINICAL LABORATORY INC (organization), BALDWIN PARK, CA; taxonomy 291U00000X; Medicaid home state MO.
  2. 2. procedures billed, Medicaid: Code U0003 (Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r): $729,801 paid over 24 months, 18% of this provider's Medicaid dollars, $120 per patient-month, which ranks at the 88th percentile of all providers billing this code (typical $75).
  3. 3. procedures billed, Medicaid: Code 87798 (Detection test by nucleic acid for organism, amplified probe technique): $672,654 paid over 49 months, 17% of this provider's Medicaid dollars, $64 per patient-month, which ranks at the 75th percentile of all providers billing this code (typical $33).
  4. 4. procedures billed, Medicaid: Code 87502 (Detection test by nucleic acid for multiple types influenza virus): $348,859 paid over 49 months, 9% of this provider's Medicaid dollars, $55 per patient-month, which ranks at the 31th percentile of all providers billing this code (typical $71).
  5. 5. procedures billed, Medicaid: Code 87631 (Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets): $279,418 paid over 31 months, 7% of this provider's Medicaid dollars, $52 per patient-month, which ranks at the 33th percentile of all providers billing this code (typical $74).
  6. 6. procedures billed, Medicaid: Code 87634 (Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique): $258,473 paid over 48 months, 7% of this provider's Medicaid dollars, $41 per patient-month, which ranks at the 39th percentile of all providers billing this code (typical $48).
  7. 7. procedures billed, Medicaid: Code G0483 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms): $206,715 paid over 25 months, 5% of this provider's Medicaid dollars, $118 per patient-month, which ranks at the 38th percentile of all providers billing this code (typical $146).
  8. 8. provider_risk: Evidence tier 1 (documented action, then payment); detectors D3; dollars at risk $3,846,471 (figure of the detector that set the tier, not a sum); reasons: Listed on the Medicare revocation list since August 31, 2018; Medicaid still paid claims in 44 later months, $3,846,471 in total.
  9. 9. Revocation_Extract: Revoked 2018-08-31 under 424.535(A)(4) False Or Misleading Information;424.535(A)(3) Felonies;424.535(A)(2) Provider Or Supplier Conduct (Exclusion); re-enrollment bar to 2034-11-22.
  10. 10. flags/D3 + T-MSIS spending: After the MEDICARE_REVOKED action of 2018-08-31 (424.535(A)(4) False Or Misleading Information;424.535(A)(3) Felonies;424.535(A)(2) Provider Or Supplier Conduct (Exclusion)), Medicaid paid $3,846,471 across 44 service months (2018-09 to 2022-04); $312,286 in the 12 months before.
  11. 11. flags/D3 + T-MSIS spending: After the STATE_EXCL_CA action of 2018-08-31 (CA Medi-Cal Suspended & Ineligible Provider List (July 2026)), Medicaid paid $3,846,471 across 44 service months (2018-09 to 2022-04); $312,286 in the 12 months before.
Your decision

Ask this case

Answers come only from the evidence tables, and every sentence cites the record it used.